GYRE THERAPEUTICS, INC. (GYRE) › EPS (Diluted)GYRE THERAPEUTICS, INC. (GYRE) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2009: $-1.542010: $0.362011: $-0.272012: $-0.212021: $-2.872022: $0.032023: $-1.412024: $0.052025: $0.02$0.022009EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$0.02-60.0%2024$0.05+103.5%2023$-1.41-4800.0%2022$0.03+101.0%2021$-2.87—2012$-0.21+22.2%2011$-0.27-175.0%2010$0.36+123.4%2009$-1.54—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share